NCT01333098View on ClinicalTrials.gov

Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Anxiety Disorders
Interventions
DRUG

Mifepristone

300mg per day, by mouth, for 21-28 days

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01333098 - Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders | Biotech Hunter | Biotech Hunter